- Home
- OPTN vs LICY Comparison
OPTN vs LICY Comparison
Compare OPTN & LICY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- LICY
- Stock Information
- Founded
- OPTN 2010
- LICY 2016
- Country
- OPTN United States
- LICY Canada
- Employees
- OPTN N/A
- LICY N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- LICY Environmental Services
- Sector
- OPTN Health Care
- LICY Industrials
- Exchange
- OPTN Nasdaq
- LICY Nasdaq
- Market Cap
- OPTN 99.7M
- LICY 83.8M
- IPO Year
- OPTN 2017
- LICY N/A
- Fundamental
- Price
- OPTN $0.46
- LICY $2.41
- Analyst Decision
- OPTN Strong Buy
- LICY Hold
- Analyst Count
- OPTN 3
- LICY 3
- Target Price
- OPTN $3.00
- LICY $5.36
- AVG Volume (30 Days)
- OPTN 617.5K
- LICY 2.3M
- Earning Date
- OPTN 11-12-2024
- LICY 11-07-2024
- Dividend Yield
- OPTN N/A
- LICY N/A
- EPS Growth
- OPTN N/A
- LICY N/A
- EPS
- OPTN N/A
- LICY N/A
- Revenue
- OPTN $75,672,000.00
- LICY $27,400,000.00
- Revenue This Year
- OPTN $24.44
- LICY $48.13
- Revenue Next Year
- OPTN $49.00
- LICY $18.15
- P/E Ratio
- OPTN N/A
- LICY N/A
- Revenue Growth
- OPTN 5.13
- LICY N/A
- 52 Week Low
- OPTN $0.44
- LICY $1.22
- 52 Week High
- OPTN $2.10
- LICY $15.36
- Technical
- Relative Strength Index (RSI)
- OPTN 28.38
- LICY 46.18
- Support Level
- OPTN $0.50
- LICY $2.69
- Resistance Level
- OPTN $0.81
- LICY $4.98
- Average True Range (ATR)
- OPTN 0.06
- LICY 0.57
- MACD
- OPTN -0.02
- LICY -0.04
- Stochastic Oscillator
- OPTN 3.23
- LICY 13.60
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.